Por favor, use este identificador para citar o enlazar este ítem:
http://conacyt.repositorioinstitucional.mx/jspui/handle/1000/3858| Cardiovascular Disease and Use of Renin-Angiotensin System Inhibitors in COVID-19 | |
| Kow Chia Siang. Zaidi Syed Tabish Razi. Hasan Syed Shahzad. | |
| Acceso Abierto | |
| Atribución-NoComercial-SinDerivadas | |
| 10.1007/s40256-020-00406-0 | |
| There is ongoing debate on the safety of renin-angiotensin system (RAS) inhibitors in COVID-19. Recently published studies highlight a potential relationship between cardiovascular disease (CVD) and COVID-19. This article aims to summarize the evidence on the use of RAS inhibitors in CVD patients with COVID-19, focusing on safety issues of the RAS inhibitors and their relationship with COVID-19. | |
| American Journal of Cardiovascular Drugs | |
| 2020 | |
| Artículo | |
| https://link.springer.com/content/pdf/10.1007/s40256-020-00406-0.pdf | |
| Inglés | |
| VIRUS RESPIRATORIOS | |
| Aparece en las colecciones: | Artículos científicos |
Cargar archivos:
| Fichero | Tamaño | Formato | |
|---|---|---|---|
| 1105364.pdf | 684.44 kB | Adobe PDF | Visualizar/Abrir |